Alternatives to Omabit

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

AI-powered platform for personalized cell therapy development and manufacturing.

AI-powered breast cancer detection and risk assessment solutions.

Data-driven software solutions for precision medicine and pharmaceutical development.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

British clinical-stage biopharma company developing a pipeline of orally-dosed, precision microbiome medicines.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.